The Review Panel (MHRA)

The Review Panel (MHRA) carries out statutory and non-statutory reviews of proposals, decisions and provisional decisions taken by Medicines and Healthcare Products Regulatory Agency.

Role of the group

The terms of reference for the Review Panel (MHRA) are to:

  • review the provisional determinations made by the Medicines and Healthcare Products Regulatory Agency (MHRA) concerning the classification of a product as a medicine
  • perform the role of the ‘reviewers’ in relation to decisions or proposals made by the MHRA related to the grant, renewal, revocation, suspension, refusal or variation of manufacturer’s or wholesale dealing licences, and UK marketing authorisations (the ‘persons appointed’ role)
  • consider representations about decisions made in relation to advertising

The Review Panel became a departmental expert committee on 1 November 2012 as a result of the Arm’s Length Body (ALB) Review in 2010.

Annual report

The Review Panel Annual Report 2015

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

The Review Panel Annual Report 2014

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

The Review Panel Annual Report 2013

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

The Review Panel's guidance note for the hearing

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

Members

The members of the panel are:

  • Mr Neil Mercer LL.B. (Hons) B.A. (Hons) Practising Barrister, Thomas Bingham Chambers, London (Chair)
  • Professor Peter Aggett OBE MSc FRCPCH FRCP Emeritus Professor of Child Health and Nutrition
  • Mrs Elizabeth Bamford MRPhS Former Director of Regulatory, Medical & Consumer Affairs, GlaxoSmithKline Healthcare UK
  • Mr Michael Carroll BSc (Hons) MBA CSci CChem FRSC MIQA Former Non-Executive Director, Health Protection Agency
  • Mr Richard Crossley LLB Non-executive Director, Fundraising Standards Board
  • Mrs Pamela Goldberg OBE Independent Consultant
  • Professor Nicola Robinson BSc (Hons) PhD DipHE LicAc Professor of Traditional Chinese Medicine (TCM) and Integrated Health, Faculty of Health and Social Care, London South Bank University
  • Dr Marion Sommerville PhD R.D. Registered Dietitian; Member of the British Dietetic Association and Registered with the Health Professions Council
  • Dr Jayne Spink BSc PhD Chief Executive of the Tuberous Sclerosis Association
  • Dr Stephen Waring PhD FRCP Consultant Physician in Acute Medicine and Clinical Toxicology, York Hospital; Honorary Senior Lecturer, Hull York Medical School
  • Dr David Webster, Retired Business Consultant, Non-Executive Director of Compass, former Non-Executive Director of East Riding NHS Primary Care Trust and Managing Director of Smith and Nephew Healthcare